2018 was a landmark year for new drug approvals. However, patients’ access to these novel drugs varied by drug category and enrolled health plan.
Naomi Bridger, BS
Advertisement
Articles by Naomi Bridger, BS
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
CDC Officially Ends Hantavirus Response as Outbreak Risk Recedes
2
Treatment Burden, End-of-Life Symptom Gaps in Multiple Myeloma
3
Health Equity & Access Weekly Roundup: June 26, 2026
4
ATTR-CM Incidence, Prevalence Rose Sharply in the US
5